title: Cost effectiveness of artificial organ technologies versus conventional therapy.
authors.affiliation: Cardiovascular Devices Division, University of Ottawa Heart Institute, Ontario, Canada.
authors.forename: T
authors.initials: T
authors.lastname: Mussivand
authors.forename: R T
authors.initials: RT
authors.lastname: Kung
authors.forename: P M
authors.initials: PM
authors.lastname: McCarthy
authors.forename: V L
authors.initials: VL
authors.lastname: Poirier
authors.forename: F A
authors.initials: FA
authors.lastname: Arabia
authors.forename: P
authors.initials: P
authors.lastname: Portner
authors.forename: K
authors.initials: K
authors.lastname: Affeld
mesh_terms: D001187:Artificial Organs / Q000191:economics*; D003362:Cost-Benefit Analysis; D006333:Heart Failure / Q000191:economics / Q000601:surgery / Q000628:therapy; D016027:Heart Transplantation / Q000191:economics; D006353:Heart-Assist Devices / Q000191:economics; D006801:Humans; D009205:Myocarditis / Q000191:economics / Q000601:surgery / Q000628:therapy; D012051:Reimbursement Mechanisms